Please Wait
Applying Filters...
menu
    • menu
    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Carbapenem

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    DoP Seeks Applications For PLI Scheme To Produce 2 Bulk Drugs
    DoP Seeks Applications For PLI Scheme To Produce 2 Bulk Drugs

    01 Dec 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=182742&sid=1

    PHARMABIZ
    01 Dec 2025
    Share Share
    Omnix Medical, Prevail Partners Unveil Strategic Financial
    Omnix Medical, Prevail Partners Unveil Strategic Financial

    06 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-06/omnix-medical-and-prevail-partners-llc-announce-strategic-and-financial-partnership

    PHARMIWEB
    06 Nov 2025
    Share Share
    Ph3 PIVOT-PO Data Show Tebipenem HBr as First Oral Carbapenem
    Ph3 PIVOT-PO Data Show Tebipenem HBr as First Oral Carbapenem

    21 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/21/3169930/0/en/PIVOT-PO-Phase-3-Data-Show-Tebipenem-HBr-s-Potential-as-the-First-Oral-Carbapenem-Antibiotic-for-Patients-with-Complicated-Urinary-Tract-Infections-cUTIs.html

    GLOBENEWSWIRE
    21 Oct 2025
    Share Share
    Spero Pharma Presents Tebipenem Hbr Data At IDweek
    Spero Pharma Presents Tebipenem Hbr Data At IDweek

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166146/0/en/Spero-Therapeutics-Announces-Presentations-on-Tebipenem-Hbr-at-IDWeek.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    iNtRON Files US Patent for 3 New Endolysin Drug Candidates
    iNtRON Files US Patent for 3 New Endolysin Drug Candidates

    02 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intron-files-us-patent-for-three-novel-endolysin-based-drug-candidates-targeting-gram-negative-bacteria-302496380.html

    PR NEWSWIRE
    02 Jul 2025
    Share Share
    GSK, Spero stop UTI drug trial after early success
    GSK, Spero stop UTI drug trial after early success

    29 May 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-spero-stop-urinary-tract-infection-drug-trial-due-early-success-2025-05-28/

    REUTERS
    29 May 2025
    Share Share